Literature DB >> 27341423

Intergenerational transmission of depressive symptoms - The role of gender, socioeconomic circumstances, and the accumulation of parental symptoms.

Janne Mikkonen1, Heta Moustgaard2, Hanna Remes2, Pekka Martikainen3.   

Abstract

BACKGROUND: The relationship between parental and offspring depression is well established. Evidence regarding the significance of gender, socioeconomic circumstances, and the accumulation of parental symptoms in intergenerational transmission is, however, mixed and scarce.
METHODS: Using a 20% random sample of Finns born between 1986 and 1996 (n=138,559), we performed a Cox proportional hazards regression to analyze the incidence of depressive symptoms between ages 15-20 by exposure to maternal and paternal depressive symptoms earlier in life. Depressive symptoms were inferred from antidepressant purchases and/or a diagnosis of depression at outpatient or inpatient health services.
RESULTS: Exposure to maternal depressive symptoms posed an equal risk for girls and boys (hazard ratio, HR, 2.09 vs. 2.28 respectively, p=0.077), whereas the effect of paternal depressive symptoms was weaker for girls (HR 1.77 vs. 2.22, p<0.001). Parental socioeconomic status neither confounded nor moderated these effects. Dual exposure to both maternal and paternal depressive symptoms posed a larger risk than single exposure, and children exposed recurrently at ages 0-5 and 9-14 faced an elevated risk compared with those exposed at only one period. LIMITATIONS: Since depressive symptoms were inferred from prescription purchases and treatment records, we were unable to observe untreated depression or to determine the underlying condition the antidepressants were prescribed for.
CONCLUSIONS: Our results support the idea that maternal depression affects both genders equally, whereas paternal depression affects girls less than boys. We show that parental depression and low socioeconomic status are mainly independent risk factors of adolescent depressive symptoms and do not cause an interactive effect.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accumulation of risk; Adolescence; Depressive symptoms; Gender; Intergenerational transmission; Socioeconomic status

Mesh:

Year:  2016        PMID: 27341423     DOI: 10.1016/j.jad.2016.06.036

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Maternal Depressive Symptoms and Adolescent Health Risk Problems: The Role of School Engagement.

Authors:  Celia J Fulco; Megan Bears Augustyn; Kimberly L Henry
Journal:  J Youth Adolesc       Date:  2019-06-04

2.  Cumulative socioeconomic status risk and observations of parent depression: Are there associations with child outcomes?

Authors:  Alexandra D Sullivan; Renee Benoit; Nicole L Breslend; Allison Vreeland; Bruce Compas; Rex Forehand
Journal:  J Fam Psychol       Date:  2019-08-15

3.  Parent's Depression as a Moderator of the Association Between Offspring's Depressive Symptoms and Use of Combustible Cigarettes and Electronic Vapor Products.

Authors:  Beom-Young Cho
Journal:  J Behav Health Serv Res       Date:  2019-10       Impact factor: 1.505

4.  Intergenerational Continuity in Depression: The Importance of Time-Varying Effects, Maternal Co-morbid Health Risk Behaviors and Child's Gender.

Authors:  Megan Bears Augustyn; Celia J Fulco; Kimberly L Henry
Journal:  J Youth Adolesc       Date:  2018-01-12

Review 5.  Transgenerational epigenetic influences of paternal environmental exposures on brain function and predisposition to psychiatric disorders.

Authors:  Shlomo Yeshurun; Anthony J Hannan
Journal:  Mol Psychiatry       Date:  2018-03-08       Impact factor: 15.992

6.  Temporal effects of maternal psychological distress on child mental health problems at ages 3, 5, 7 and 11: analysis from the UK Millennium Cohort Study.

Authors:  Steven Hope; Anna Pearce; Catherine Chittleborough; Jessica Deighton; Amelia Maika; Nadia Micali; Murthy Mittinty; Catherine Law; John Lynch
Journal:  Psychol Med       Date:  2018-06-11       Impact factor: 7.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.